ArticleBlood advances2025

Antibody-DNA nanostructure conjugates integrate doxorubicin and rituximab to enhance therapeutic efficacy for DLBCL.

Zuguang Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.